Cargando…

Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata

BACKGROUND/AIM: Alopecia areata (AA) is an inflammatory disease with a genetic and autoimmune basis. Herein, it was aimed to study the efficacy and safety of an immunomodulatory therapeutic agent, diphenylcyclopropenone, while manifesting its association with histopathological features, prognostic f...

Descripción completa

Detalles Bibliográficos
Autores principales:	KUTLUBAY, Zekayi, SEVİM KEÇİCİ, Ayşegül, AYDIN, Övgü, VEHİD, Suphi, SERDAROĞLU, Server
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775697/ https://www.ncbi.nlm.nih.gov/pubmed/31655499 http://dx.doi.org/10.3906/sag-1807-230

Ejemplares similares

Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
por: Aghaei, Shahin
Publicado: (2005)

The Association between the Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study
por: Gencebay, Güllü, et al.
Publicado: (2022)

Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
por: Nowicka, Danuta, et al.
Publicado: (2018)

A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up
por: KUTLUBAY, Zekayi, et al.
Publicado: (2021)

Treatment satisfaction and response in patients with severe alopecia areata under treatment with diphenylcyclopropenone
por: Abedini, Robabeh, et al.
Publicado: (2022)

Treatment of alopecia areata with Diphenylcyclopropenone: methodology based on the principles of allergic contact dermatitis()
por: Lopes, Andressa Sato de Aquino, et al.
Publicado: (2022)

Comparative Study of Efficacy and Safety of Topical Squaric Acid Dibutylester and Diphenylcyclopropenone for the Treatment of Alopecia Areata
por: Tiwary, Anup K., et al.
Publicado: (2016)

Conventional and Novel Treatment Modalities in Rosacea
por: Engin, Burhan, et al.
Publicado: (2020)

A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata
por: Sriphojanart, Tueboon, et al.
Publicado: (2017)

A Case Report of Verruca Vulgaris on basis of Alopecia Areata Successfully Treated with Diphenylcyclopropenone
por: Uzuncakmak, Tugba Kevser, et al.
Publicado: (2017)

Can the Cytokine Analysis of the Scales on Alopecic Patch Predict the Response to Diphenylcyclopropenone Treatment in Alopecia Areata Patients?
por: Lee, Si Hyub, et al.
Publicado: (2018)

Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study
por: Thuangtong, Rattapon, et al.
Publicado: (2022)

A Rare Association of Childhood Alopecia Areata and Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome: Successfully Treated with Diphenylcyclopropenone
por: Jagadeesan, Soumya, et al.
Publicado: (2015)

Evaluation of Quality of Life in Children and Adolescents Diagnosed with Striae Distensae
por: Aşkın, Özge, et al.
Publicado: (2021)

Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis
por: Riad, Hassan, et al.
Publicado: (2013)

Evaluation of Advanced Oxidation Protein Products, Prooxidant-Antioxidant Balance, and Total Antioxidant Capacity in Untreated Vitiligo Patients
por: Güntaş, Gülcan, et al.
Publicado: (2015)

Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata()()
por: Aşkın, Özge, et al.
Publicado: (2021)

Turkish PASE: Turkish Version of the Psoriatic Arthritis Screening and Evaluation Questionnaire
por: Oyur, Kadir Berat, et al.
Publicado: (2014)

THE EFFICACY OF TOPICAL DIPHENCYPRONE IN THE TREATMENT OF ALOPECIA AREATA
por: Maryam, Akhyani, et al.
Publicado: (2009)

Alopecia Areata
Publicado: (1908)

Alopecia Areata
por: Reid, Thomas
Publicado: (1869)

Alopecia Areata
por: Spangenthal, Joseph
Publicado: (1898)

Efficacy and safety of methotrexate in alopecia areata
por: Hammerschmidt, Mariana, et al.
Publicado: (2014)

Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023)

Efficacy of Korean Red Ginseng in the Treatment of Alopecia Areata
por: Oh, Ga Na, et al.
Publicado: (2012)

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
por: Anzengruber, Florian, et al.
Publicado: (2016)

Long-Term Efficacy of Dupilumab in Alopecia Areata
por: Kulkarni, Maansi, et al.
Publicado: (2022)

Management of alopecia areata
por: Harries, M J, et al.
Publicado: (2010)

Alopecia areata incognita
por: Molina, Luciana, et al.
Publicado: (2011)

IS ALOPECIA AREATA PSYCHOSOMATIC ?
por: Devar, J.V.
Publicado: (1983)

Linear Alopecia Areata
por: Shetty, Shricharith, et al.
Publicado: (2016)

Ringworm and Alopecia Areata
Publicado: (1898)

The Etiology of Alopecia Areata
Publicado: (1904)

Linear alopecia areata
por: Yu, Lijuan, et al.
Publicado: (2018)

The Fungus of Alopecia Areata
Publicado: (1874)

Immunology of alopecia areata
por: ŻEBERKIEWICZ, MARTA, et al.
Publicado: (2020)

The Naming of Alopecia Areata
por: Montgomery, Douglass W.
Publicado: (1931)

Immunopathogenesis of alopecia areata
por: Olayinka, Jadesola (Jadé) Temitope, et al.
Publicado: (2021)

New aspects of the treatment of alopecia areata
por: Brzezińska-Wcisło, Ligia, et al.
Publicado: (2014)

Topical tofacitinib in treatment of alopecia areata
por: Ferreira, Sineida Berbert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gou3npcv3hlub4spru3au9l6fp